Source: Eur Respir J 2006; 27: 957-963
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Guddo F., Vignola A. M., Saetta M., Baraldo S., Siena L., Balestro E., Zuin R., Papi A., Maestrelli P., Fabbri L. M., Bonsignore G., Turato G.. Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis. Eur Respir J 2006; 27: 957-963

Member's Comments

No comment yet.

Related content which might interest you: Increased levels of epidermal growth factor in sputum of smoking chronic bronchitis patients Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003 Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001 Expression of epidermal growth factor receptor (EGFR) in the bronchial epithelium of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Decrease of vascular endothelial growth factor in macrophages from long-term smokers Source: Eur Respir J 2005; 25: 626-633 Year: 2005 Hypoxia inducible factor-1? in human emphysema lung tissue Source: Eur Respir J 2011; 37: 775-783 Year: 2011 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma Source: Eur Respir J 2006; 27: 208-229 Year: 2006 Placenta growth factor (PlGF) triggers small airway remodeling (SAR) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017 Role of tumour necrosis factor-α receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema Source: Eur Respir J 2006; 28: 102-112 Year: 2006 Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 Altered expression of the Smad signalling pathway: implications for COPD pathogenesis Source: Eur Respir J 2006; 28: 533-541 Year: 2006 Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006 Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity Source: Eur Respir J 2003; 21: 842-847 Year: 2003 Hepatocyte growth factor prevents airway remodelling in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003 Airway epithelial cells from asymptomatic smokers but not from smokers with chronic bronchitis and COPD have increased C/EBP transcription factor activity Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004 Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD Source: Eur Respir J 2006; 28: 556-562 Year: 2006 Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-?B and EGFR pathways Source: Eur Respir J 2010; 36: 1425-1435 Year: 2010 Pulmonary vascular involvement in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 28S-32S Year: 2003 Cigarette smoke-induced pulmonary inflammation, but not airway wall remodeling, is attenuated in CCR5 deficient mice Source: Annual Congress 2007 - The best of airway epithelial cells Year: 2007